Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b
Kathryn C. Fitzgerald(Johns Hopkins University), Alberto Ascherio(Brigham and Women's Hospital), Karl Köchert(Max Delbrück Center), Gıancarlo Comı(Vita-Salute San Raffaele University), Ludwig Kappos(Novartis (Switzerland)), Christoph Pohl, Rupert Sandbrink(Io Therapeutics (United States)), Kassandra L. Munger(Harvard University), Gustavo Cruz(Düsseldorf University Hospital), Douglas Jeffery(University of New Mexico), Barry G.W. Arnason, Paul O’Connor(St. Michael's Hospital), Hans-Peter Hartung(The University of Sydney), Massimo Filippi(Vita-Salute San Raffaele University), Stuart D. Cook(Rutgers, The State University of New Jersey), Douglas S. Goodin(San Francisco VA Medical Center)
Cited by 169
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
|New England Journal of Medicine|1993|2.4k